CAS 475-67-2: (+)-Isocorydine

Isocorydine is an alkaloid compound, which is derived from natural sources, specifically from the plant Stephania glabra. It belongs to the class of benzylisoquinoline alkaloids, which are known for their diverse pharmacological activities. The mode of action of Isocorydine involves interference with cellular signaling pathways, primarily impacting cancer cells by inducing apoptosis, inhibiting cell proliferation, and modulating key regulatory proteins associated with cancer progression. Studies suggest that Isocorydine holds promise as a therapeutic agent, particularly in the field of oncology. It has been observed to exhibit significant antitumor effects across various cancer cell lines, indicating its potential use as an adjunct in cancer treatment regimens. Researchers are actively exploring its mechanism to harness its benefits fully, and ongoing studies are focused on elucidating its efficacy and safety profile in vivo. Additionally, due to its natural origin, Isocorydine may offer an alternative or complement to existing synthetic pharmaceuticals in oncology.

Isocorydine

Isocorydine is an alkaloid compound, which is a naturally occurring chemical substance derived from plants, specifically from the Papaveraceae family. It exhibits a range of pharmacological activities that make it of interest to the scientific community. The mode of action of isocorydine is primarily associated with its interaction with cellular pathways involved in apoptosis, or programmed cell death, which is a critical mechanism in cancer treatment strategies. Isocorydine has been studied extensively for its potential applications in oncology. It is known to inhibit the growth of various cancer cell lines, making it a promising candidate for further research into anticancer therapies. Its ability to induce apoptosis and interfere with cell cycle progression highlights its potential as a therapeutic agent. Additionally, the compound's natural origin allows for the exploration of its biosynthetic pathways and derivatives, which could lead to the development of novel drugs with improved efficacy and safety profiles. Research continues to investigate the detailed mechanisms by which isocorydine acts, as well as its possible synergistic effects when used in combination with other therapeutic agents.

S-Isocorydine (Uzokoridin)(+) and its derivatives have anticancer activities.